One-Third of Patients Don't Retain Important Warfarin Info

This article originally appeared here.
Share this content:
One-Third of Patients Don't Retain Important Warfarin Info
One-Third of Patients Don't Retain Important Warfarin Info

FRIDAY, Aug. 12, 2016 (HealthDay News) -- Just over two-thirds of patients retain an "acceptable" amount of key information following warfarin counseling, according to a small study published online Aug. 6 in the Journal of Pharmacy Practice and Research.

Nashwa Masnoon, B.Pharm., from the Royal Adelaide Hospital in Australia, and colleagues evaluated the extent to which 22 patients retained information after counseling from a clinical pharmacist about the anticoagulant warfarin. The authors used assessments immediately after counseling and six weeks after counseling. Participants newly initiated warfarin in the hospital, had intact cognition, and were expected to self-administer warfarin after discharge.

The researchers found that participants recalled an average of 79.9 percent of key information elements immediately after counseling, which was significantly higher than that seen at six weeks after counseling (71.0 percent; P = 0.02). The proportion of participants achieving an "acceptable" score for knowledge was 68.2 percent at the immediate assessment and six weeks later. Six weeks after counseling, there were no significant relationships seen between specific case characteristics and patient outcomes, duration of counseling, or overall warfarin knowledge retention scores.

"These findings imply that more emphasis should be placed on educating patients on the critical information elements for warfarin counseling," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

SABCS: Artificial Intelligence May Aid Doctors in Breast Cancer Care

SABCS: Artificial Intelligence May Aid Doctors in Breast ...

'Watson Oncology' agreed with doctors 90 percent of the time in many cases, researchers find

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

Devices reduce blood flow to hair follicles during chemotherapy treatments

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

Women on aromatase inhibitors exhibit less elasticity in their blood vessels

is free, fast, and customized just for you!

Already a member?

Sign In Now »